NASDAQ:OCGN
Ocugen Stock News
$1.59
-0.0800 (-4.79%)
At Close: May 10, 2024
Ocugen (OCGN) Reports Q1 Loss, Misses Revenue Estimates
09:03am, Friday, 06'th May 2022
Ocugen (OCGN) delivered earnings and revenue surprises of -280% and 100%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
MALVERN, Pa., May 02, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing and commercializing novel gene therapies, biologicals and vaccine
2 Small-Cap Stocks With Monster Upsides, According to Wall Street
11:15am, Saturday, 30'th Apr 2022
Sometimes analysts are on the spot, and other times, not so much.
MALVERN, Pa., April 29, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing and commercializing novel gene therapies, biologicals and vacci
Is It Too Late to Buy Ocugen Stock?
11:00am, Thursday, 28'th Apr 2022
Could the hype surrounding this once-popular meme stock return?
The FDA Just Sent Ocugen a Warning. Should Investors Care?
09:05am, Thursday, 28'th Apr 2022
Regulators are displeased, and might inflict a penalty on the biopharmaceutical company.
Ocugen, Inc. to Present at NobleCon18
05:32pm, Tuesday, 19'th Apr 2022
MALVERN, Pa., April 19, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals and vacc
Why Ocugen Stock Tumbled by Nearly 6% Today
07:25pm, Monday, 18'th Apr 2022
Investors were probably concerned the expansion of a licensing deal was pricey.
Why Ocugen Shares Are Trading Higher Today
09:01am, Monday, 18'th Apr 2022
Ocugen Inc (NASDAQ: OCGN) and Bharat Biotech have amended their co-development, supply, and commercialization agreement to expand Ocugen's exclusive territory to include the commercialization of C
2 Red Flags for Ocugen's Future
11:30am, Sunday, 17'th Apr 2022
The company's prospects aren't getting better.
State Street Just Bought Ocugen (OCGN) Stock. Here's Why.
02:30pm, Thursday, 14'th Apr 2022
OCGN stock has declined by over 90% in the past five years. However, that hasn't stopped State Street from more than doubling its position.
Ocugen (OCGN) Stock Down as FDA Puts Hold on Covaxin Study
11:17am, Wednesday, 13'th Apr 2022
Ocugen (OCGN) is conducting the OCU-002 study to support its BLA for the approval of Covaxin in the United States. The FDA places a clinical hold on this study.
Why Is Ocugen (OCGN) Stock Down Today?
11:34am, Tuesday, 12'th Apr 2022
Shares of OCGN stock are trading lower after the FDA announced that it had placed a clinical hold on Covaxin. Here's what you should know.
Ocugen stock drops after FDA places clinical hold on study of COVID-19 vaccine candidate Covaxin
09:11am, Tuesday, 12'th Apr 2022
Shares of Ocugen Inc. OCGN, -2.03% sank 6.9% premarket, after the biotechnology company said the U.S. Food and Drug Administration placed a "clinical hold" on the Phase 2/3 study of its COVID-19 vacci
3 COVID-19 Stocks With Monster Upside of Up to 355%, According to Wall Street
09:21am, Wednesday, 06'th Apr 2022 The Motley Fool
Select analysts foresee these coronavirus stocks rocketing higher by 246% to 355% over the next year.
